(Q38047647)

27 August 2017

Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases (English)

1 reference

27 August 2017

0 references

Farinaz Safavi

1

1 reference

PubMed ID

23022357

27 August 2017

Abdolmohamad Rostami

series ordinal

2

1 reference

27 August 2017

27 September 2012

1 reference

Experimental and Molecular Pathology

27 August 2017

1 reference

27 August 2017

93

1 reference

27 August 2017

3

1 reference

27 August 2017

428-433

1 reference

Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis

27 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Chronic urticaria: a disease at a crossroad between autoimmunity and coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Protease inhibitor suppression of colon and anal gland carcinogenesis induced by dimethylhydrazine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Cloning of a novel MHC-encoded serine peptidase highly expressed by cortical epithelial cells of the thymus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

c-fos mRNA levels are reduced in the presence of antipain and Bowman-Birk inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Nafamostat mesilate attenuates colonic inflammation and mast cell infiltration in the experimental colitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Critical regulation of early Th17 cell differentiation by interleukin-1 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Protease inhibitors suppress in vitro growth of human small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Bowman-Birk inhibitors from legumes and human gastrointestinal health: current status and perspectives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Bowman-Birk Inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Apoptosis and lysosome membrane permeabilization induction on breast cancer cells by an anticarcinogenic Bowman-Birk protease inhibitor from Vigna unguiculata seeds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Serine protease inhibitor, 4-(2-aminoethyl)-benzene sulfonyl fluoride, impairs IL-12-induced activation of pSTAT4β, NFκB, and select pro-inflammatory mediators from estrogen-treated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Expanding the clinical indications for α(1)-antitrypsin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Bowman-Birk inhibitor concentrate: a novel therapeutic agent for patients with active ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

A critical role for neutrophil elastase in experimental bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

The biochemical and functional food properties of the bowman-birk inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Matrix metalloproteinases as modulators of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Dual inhibition of cathepsin G and chymase is effective in animal models of pulmonary inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

A proteolytic activity in a human breast cancer cell line which is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Thrombin receptor expression and responsiveness of human monocytic cells to thrombin is linked to interferon-induced cellular differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Proteinase 3 is an IL-32 binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Matrix metalloproteinases: a review of their structure and role in systemic sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Neutrophil serine proteases fine-tune the inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Thrombin and vascular inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Human and mouse proteases: a comparative genomic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Matrix metalloproteinases and neuroinflammation in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Interleukin-10 prevents experimental allergic encephalomyelitis in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

The regulation of IL-10 production by immune cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Serine protease inhibitor attenuates ovalbumin induced inflammation in mouse model of allergic airway disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

How neutrophils kill microbes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Matrix metalloproteinases in vascular physiology and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Sustained expression of circulating human alpha-1 antitrypsin reduces inflammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Novel aspects and new roles for the serine protease plasmin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Plasmin as a proinflammatory cell activator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

The neutrophil granule protein cathepsin G activates murine T lymphocytes and upregulates antigen-specific IG production in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Granzymes: a family of lymphocyte granule serine proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Complement. First of two parts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Inhibition of membrane-type serine protease 1/matriptase by natural and synthetic protease inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Thrombin regulates the function of human blood dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

C1-inhibitor: more than a serine protease inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.09.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEXMP.2012.09.014

1 reference

27 August 2017

1 reference

PubMed ID

23022357